Logo image of NLSN

NIELSEN HOLDINGS PLC (NLSN) Stock Fundamental Analysis

NYSE:NLSN - New York Stock Exchange, Inc. - GB00BWFY5505 - Common Stock - Currency: USD

27.98  +0.01 (+0.04%)

After market: 27.99 +0.01 (+0.04%)

Fundamental Rating

2

Overall NLSN gets a fundamental rating of 2 out of 10. We evaluated NLSN against 82 industry peers in the Professional Services industry. NLSN may be in some trouble as it scores bad on both profitability and health. NLSN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NLSN was profitable.
NLSN had a positive operating cash flow in the past year.
NLSN Yearly Net Income VS EBIT VS OCF VS FCFNLSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 500M -500M 1B

1.2 Ratios

Industry RankSector Rank
ROA 4.86%
ROE 15.26%
ROIC 6.42%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NLSN Yearly ROA, ROE, ROICNLSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20 -20

1.3 Margins

NLSN's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of NLSN has grown nicely.
Industry RankSector Rank
OM 23.51%
PM (TTM) 14.99%
GM N/A
OM growth 3Y28.76%
OM growth 5Y6.33%
PM growth 3YN/A
PM growth 5Y43.28%
GM growth 3YN/A
GM growth 5YN/A
NLSN Yearly Profit, Operating, Gross MarginsNLSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

NLSN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, NLSN has more shares outstanding
NLSN has a better debt/assets ratio than last year.
NLSN Yearly Shares OutstandingNLSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M
NLSN Yearly Total Debt VS Total AssetsNLSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 5B 10B 15B

2.2 Solvency

NLSN has an Altman-Z score of 1.46. This is a bad value and indicates that NLSN is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of NLSN is 8.68, which is on the high side as it means it would take NLSN, 8.68 years of fcf income to pay off all of its debts.
NLSN has a Debt/Equity ratio of 1.61. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF 8.68
Altman-Z 1.46
ROIC/WACC0.88
WACC7.27%
NLSN Yearly LT Debt VS Equity VS FCFNLSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 2.04 indicates that NLSN has no problem at all paying its short term obligations.
A Quick Ratio of 2.04 indicates that NLSN has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 2.04
NLSN Yearly Current Assets VS Current LiabilitesNLSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for NLSN have decreased by -2.15% in the last year.
The Earnings Per Share has been decreasing by -6.84% on average over the past years.
The Revenue for NLSN has decreased by -28.72% in the past year. This is quite bad
The Revenue for NLSN have been decreasing by -11.12% on average. This is quite bad
EPS 1Y (TTM)-2.15%
EPS 3Y23.97%
EPS 5Y-6.84%
EPS Q2Q%6.98%
Revenue 1Y (TTM)-28.72%
Revenue growth 3Y-18.71%
Revenue growth 5Y-11.12%
Sales Q2Q%2.44%

3.2 Future

Based on estimates for the next years, NLSN will show a small growth in Earnings Per Share. The EPS will grow by 5.62% on average per year.
NLSN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.21% yearly.
EPS Next Y6.17%
EPS Next 2Y5.15%
EPS Next 3Y6.05%
EPS Next 5Y5.62%
Revenue Next Year2.38%
Revenue Next 2Y3.15%
Revenue Next 3Y3.41%
Revenue Next 5Y3.21%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NLSN Yearly Revenue VS EstimatesNLSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B
NLSN Yearly EPS VS EstimatesNLSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.37, NLSN is valued correctly.
Compared to an average S&P500 Price/Earnings ratio of 29.63, NLSN is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 13.98, the valuation of NLSN can be described as correct.
The average S&P500 Price/Forward Earnings ratio is at 22.68. NLSN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.37
Fwd PE 13.98
NLSN Price Earnings VS Forward Price EarningsNLSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF 15.56
EV/EBITDA 11.18
NLSN Per share dataNLSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NLSN does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.49
PEG (5Y)N/A
EPS Next 2Y5.15%
EPS Next 3Y6.05%

More info and screens

3

5. Dividend

5.1 Amount

NLSN has a yearly dividend return of 0.86%, which is pretty low.
Compared to an average S&P500 Dividend Yield of 2.27, NLSN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.86%

5.2 History

The dividend of NLSN decreases each year by -44.32%.
NLSN has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-44.32%
Div Incr YearsN/A
Div Non Decr YearsN/A
NLSN Yearly Dividends per shareNLSN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 0.2 0.4 0.6 0.8 1

5.3 Sustainability

16.23% of the earnings are spent on dividend by NLSN. This is a low number and sustainable payout ratio.
DP16.23%
EPS Next 2Y5.15%
EPS Next 3Y6.05%
NLSN Yearly Income VS Free CF VS DividendNLSN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 0 500M -500M
NLSN Dividend Payout.NLSN Dividend Payout, showing the Payout Ratio.NLSN Dividend Payout.PayoutRetained Earnings

More info and screens

NIELSEN HOLDINGS PLC

NYSE:NLSN (10/11/2022, 8:25:24 PM)

After market: 27.99 +0.01 (+0.04%)

27.98

+0.01 (+0.04%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)07-27 2022-07-27/bmo
Earnings (Next)11-04 2022-11-04/bmo
Inst Owners0.01%
Inst Owner Change0%
Ins Owners10.9%
Ins Owner Change0%
Market Cap10.07B
Analysts71.43
Price Target28.56 (2.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.86%
Yearly Dividend0.24
Dividend Growth(5Y)-44.32%
DP16.23%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.58%
Min EPS beat(2)6.72%
Max EPS beat(2)10.45%
EPS beat(4)4
Avg EPS beat(4)16.96%
Min EPS beat(4)6.72%
Max EPS beat(4)26.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.28%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)-2.21%
Revenue beat(4)0
Avg Revenue beat(4)-1.93%
Min Revenue beat(4)-2.41%
Max Revenue beat(4)-0.73%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.37
Fwd PE 13.98
P/S 2.85
P/FCF 15.56
P/OCF 10.25
P/B 2.9
P/tB N/A
EV/EBITDA 11.18
EPS(TTM)1.82
EY6.5%
EPS(NY)2
Fwd EY7.15%
FCF(TTM)1.8
FCFY6.43%
OCF(TTM)2.73
OCFY9.75%
SpS9.82
BVpS9.65
TBVpS-15.24
PEG (NY)2.49
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.86%
ROE 15.26%
ROCE N/A
ROIC 6.42%
ROICexc N/A
ROICexgc 51.61%
OM 23.51%
PM (TTM) 14.99%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y4.08%
ROICexcg growth 5Y-0.34%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y28.76%
OM growth 5Y6.33%
PM growth 3YN/A
PM growth 5Y43.28%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF 8.68
Debt/EBITDA N/A
Cap/Depr 64.92%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 122.08%
Current Ratio 2.04
Quick Ratio 2.04
Altman-Z 1.46
F-Score6
WACC7.27%
ROIC/WACC0.88
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.15%
EPS 3Y23.97%
EPS 5Y-6.84%
EPS Q2Q%6.98%
EPS Next Y6.17%
EPS Next 2Y5.15%
EPS Next 3Y6.05%
EPS Next 5Y5.62%
Revenue 1Y (TTM)-28.72%
Revenue growth 3Y-18.71%
Revenue growth 5Y-11.12%
Sales Q2Q%2.44%
Revenue Next Year2.38%
Revenue Next 2Y3.15%
Revenue Next 3Y3.41%
Revenue Next 5Y3.21%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.59%
FCF growth 3Y-15.47%
FCF growth 5Y-17.74%
OCF growth 1Y-12.94%
OCF growth 3Y-14.3%
OCF growth 5Y-12.47%